Coherus Oncology, Inc. Loans Payable, Noncurrent
Coherus Oncology, Inc. (CHRS) had Loans Payable, Noncurrent of $75.51 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes and Loans, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2022-02-23
- 2021-12-31: Loans Payable, Noncurrent $75.51M.
- 2021-09-30: Loans Payable, Noncurrent $57.92M.
- 2021-06-30: Loans Payable, Noncurrent $63.42M.
- 2021-03-31: Loans Payable, Noncurrent $74.70M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2021-12-31 | $75.51M 10-K · filed 2022-02-23 |
| 2021-09-30 | $57.92M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $63.42M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $74.70M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $74.48M 10-K · filed 2022-02-23 |
| 2020-09-30 | $74.27M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $74.06M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $73.86M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $73.66M 10-K · filed 2021-02-25 |
| 2019-09-30 | $73.47M 10-Q · filed 2019-11-08 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |